Skip to main content
Clinical Trials/NCT05864898
NCT05864898
Not yet recruiting
Not Applicable

Predictors of Failure of Non-invasive Ventilation and High Flow Nasal Cannula in Acute Respiratory Failure Patients : the Standardized PaO2 / FiO2 Ratio (P /F-st), ROX Index and HACOR

Assiut University0 sites120 target enrollmentJuly 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Respiratory Failure Patients on NIV and HFNC
Sponsor
Assiut University
Enrollment
120
Primary Endpoint
Determine Golden time for intubation
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

Comparison between some predictors of failure of non-invasive ventilation and high flow nasal cannula.

Detailed Description

Delayed intubation after NIV / HFNC failure is associated with high mortality rate in acute respiratory failure patients. There are Many factors to predict early failure but World still searching for new factors and comparing between each ;in order to eatablish best one that achieve the least mortality rate. Little studies about effiecacy of HACOR Score as a predictor of failure in HFNC patients. Little studies about effiecacy of ROX Index as a predictor of failure in NIV ventilating patients.

Registry
clinicaltrials.gov
Start Date
July 1, 2023
End Date
July 1, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hussein Makarem

Resident doctor

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Acute respiratory failure patients who need ventilatory Support either NIV or HFNC due to :
  • RR \> 25 cycle / min
  • using accessory muscles and paradoxical breath.
  • PaO2 / FiO2 ratio \< 300

Exclusion Criteria

  • Absolute indication for intubation like coma, haemodynamically unstable... etc
  • Contr-indication of NIV like untreated Pneumothorax.

Outcomes

Primary Outcomes

Determine Golden time for intubation

Time Frame: 1 year

Determine best time for intubation according to some predictors of failure of NIV and HFNC

Similar Trials